Nectar Lifesciences to Engage with Analysts and Investors at Upcoming Conference - MSN
3 days ago • Google News
Nectar Lifesciences Limited (NECLIFE)
NSEINR 23.945%
Price Chart
Key Statistics
Market Cap
INR 7.84B
P/E Ratio
74.43
Revenue (TTM)
INR 16.49B
Volume
4.69M
52W High
INR 56.50
52W Low
INR 22.60
Dividend Yield
0.00%
Beta
1.03
Technicals
50-Day MA
39.9494
200-Day MA
35.3992
52 Week High
56.5
52 Week Low
22.6
About NECLIFE
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime.
Employees
1686
Headquarters
Chandigarh, India
CEO
Mr. Sanjiv Goyal
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg